Legal & General Group
CRDF icon

Legal & General Group’s Cardiff Oncology CRDF Stock Holding History

Legal & General Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.25K Sell
5,709
-476
-8% -$978 ﹤0.01% 3197
2025
Q4 		$17.4K Hold
6,185
– – ﹤0.01% 3086
2025
Q3 		$12.7K Hold
6,185
– – ﹤0.01% 3223
2025
Q2 		$19.5K Buy
6,185
+633
+11% +$1.93K ﹤0.01% 3012
2025
Q1 		$17.4K Buy
5,552
+1,728
+45% +$6.83K ﹤0.01% 2987
2024
Q4 		$16.6K Hold
3,824
– – ﹤0.01% 3095
2024
Q3 		$10.2K Hold
3,824
– – ﹤0.01% 3266
2024
Q2 		$8.55K Buy
+3,824
New +$14.4K ﹤0.01% 3329
2022
Q2 		– Sell
-2,886
Closed -$7K – 3550
2022
Q1 		$7K Hold
2,886
– – ﹤0.01% 3466
2021
Q4 		$17K Hold
2,886
– – ﹤0.01% 3321
2021
Q3 		$19K Hold
2,886
– – ﹤0.01% 3292
2021
Q2 		$19K Buy
+2,886
New +$24.5K ﹤0.01% 3306
2017
Q2 		– Sell
-54
Closed -$4K – 3360
2017
Q1 		$4K Hold
54
– – ﹤0.01% 3245
2016
Q4 		$8K Buy
+54
New +$12.6K ﹤0.01% 3248

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Legal & General Group's CRDF Position: Q1 2026 in Review

Legal & General Group reduced its Cardiff Oncology (CRDF) stake by 7.7% in Q1 2026, selling an estimated $978 and leaving 5,709 shares worth $9.25K. The position accounts for ﹤0.01% of the portfolio, ranked #3197.

Legal & General Group first reported a position in CRDF in Q4 2016 and has held it in 14 quarters since. The position peaked at $19.5K in Q2 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Legal & General Group held 5,709 shares of Cardiff Oncology worth $9.25K as of Q1 2026.
  • Legal & General Group sold 476 Cardiff Oncology shares in Q1 2026, an estimated $978.
  • Cardiff Oncology made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #3197 holding.
  • Legal & General Group first reported a position in Cardiff Oncology in Q4 2016 and has held it in 14 quarters since.
  • Legal & General Group's Cardiff Oncology position peaked at $19.5K in Q2 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.